Pre-order Enquiry
Request Free Sample
Global Drug Safety and Pharmacovigilance (PV) Software Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
SKU ID : QYR-18699517 | Publishing Date : 06-Jul-2021 | No. of pages : 117
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Drug Safety and Pharmacovigilance (PV) Software Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
1 Market Overview of Drug Safety and Pharmacovigilance (PV) Software1.1 Drug Safety and Pharmacovigilance (PV) Software Market Overview
1.1.1 Drug Safety and Pharmacovigilance (PV) Software Product Scope
1.1.2 Drug Safety and Pharmacovigilance (PV) Software Market Status and Outlook
1.2 Global Drug Safety and Pharmacovigilance (PV) Software Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2016-2027)
1.4 Global Drug Safety and Pharmacovigilance (PV) Software Historic Market Size by Region (2016-2021)
1.5 Global Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027)
1.6.1 North America Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027)
1.6.2 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027)
1.6.3 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027)
1.6.4 Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027)
1.6.5 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027)
2 Drug Safety and Pharmacovigilance (PV) Software Market Overview by Type
2.1 Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Drug Safety and Pharmacovigilance (PV) Software Historic Market Size by Type (2016-2021)
2.3 Global Drug Safety and Pharmacovigilance (PV) Software Forecasted Market Size by Type (2022-2027)
2.4 On-Premises
2.5 Cloud-Based
3 Drug Safety and Pharmacovigilance (PV) Software Market Overview by Application
3.1 Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Drug Safety and Pharmacovigilance (PV) Software Historic Market Size by Application (2016-2021)
3.3 Global Drug Safety and Pharmacovigilance (PV) Software Forecasted Market Size by Application (2022-2027)
3.4 Pharma and Biotech Companies
3.5 Contract Research Organizations (CROs)
3.6 Business Process Outsourcing (BPO) Firms
3.7 Other
4 Drug Safety and Pharmacovigilance (PV) Software Competition Analysis by Players
4.1 Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug Safety and Pharmacovigilance (PV) Software as of 2020)
4.3 Date of Key Players Enter into Drug Safety and Pharmacovigilance (PV) Software Market
4.4 Global Top Players Drug Safety and Pharmacovigilance (PV) Software Headquarters and Area Served
4.5 Key Players Drug Safety and Pharmacovigilance (PV) Software Product Solution and Service
4.6 Competitive Status
4.6.1 Drug Safety and Pharmacovigilance (PV) Software Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 ArisGlobal (US)
5.1.1 ArisGlobal (US) Profile
5.1.2 ArisGlobal (US) Main Business
5.1.3 ArisGlobal (US) Drug Safety and Pharmacovigilance (PV) Software Products, Services and Solutions
5.1.4 ArisGlobal (US) Drug Safety and Pharmacovigilance (PV) Software Revenue (US$ Million) & (2016-2021)
5.1.5 ArisGlobal (US) Recent Developments
5.2 Ennov Solutions Inc. (US)
5.2.1 Ennov Solutions Inc. (US) Profile
5.2.2 Ennov Solutions Inc. (US) Main Business
5.2.3 Ennov Solutions Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Products, Services and Solutions
5.2.4 Ennov Solutions Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Revenue (US$ Million) & (2016-2021)
5.2.5 Ennov Solutions Inc. (US) Recent Developments
5.3 EXTEDO GmbH (US)
5.5.1 EXTEDO GmbH (US) Profile
5.3.2 EXTEDO GmbH (US) Main Business
5.3.3 EXTEDO GmbH (US) Drug Safety and Pharmacovigilance (PV) Software Products, Services and Solutions
5.3.4 EXTEDO GmbH (US) Drug Safety and Pharmacovigilance (PV) Software Revenue (US$ Million) & (2016-2021)
5.3.5 Online Business Applications, Inc. (US) Recent Developments
5.4 Online Business Applications, Inc. (US)
5.4.1 Online Business Applications, Inc. (US) Profile
5.4.2 Online Business Applications, Inc. (US) Main Business
5.4.3 Online Business Applications, Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Products, Services and Solutions
5.4.4 Online Business Applications, Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Revenue (US$ Million) & (2016-2021)
5.4.5 Online Business Applications, Inc. (US) Recent Developments
5.5 Oracle Corporation (US)
5.5.1 Oracle Corporation (US) Profile
5.5.2 Oracle Corporation (US) Main Business
5.5.3 Oracle Corporation (US) Drug Safety and Pharmacovigilance (PV) Software Products, Services and Solutions
5.5.4 Oracle Corporation (US) Drug Safety and Pharmacovigilance (PV) Software Revenue (US$ Million) & (2016-2021)
5.5.5 Oracle Corporation (US) Recent Developments
5.6 Sarjen Systems Pvt. Ltd (India)
5.6.1 Sarjen Systems Pvt. Ltd (India) Profile
5.6.2 Sarjen Systems Pvt. Ltd (India) Main Business
5.6.3 Sarjen Systems Pvt. Ltd (India) Drug Safety and Pharmacovigilance (PV) Software Products, Services and Solutions
5.6.4 Sarjen Systems Pvt. Ltd (India) Drug Safety and Pharmacovigilance (PV) Software Revenue (US$ Million) & (2016-2021)
5.6.5 Sarjen Systems Pvt. Ltd (India) Recent Developments
5.7 Sparta Systems, Inc. (US)
5.7.1 Sparta Systems, Inc. (US) Profile
5.7.2 Sparta Systems, Inc. (US) Main Business
5.7.3 Sparta Systems, Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Products, Services and Solutions
5.7.4 Sparta Systems, Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Revenue (US$ Million) & (2016-2021)
5.7.5 Sparta Systems, Inc. (US) Recent Developments
5.8 United BioSource Corporation (US)
5.8.1 United BioSource Corporation (US) Profile
5.8.2 United BioSource Corporation (US) Main Business
5.8.3 United BioSource Corporation (US) Drug Safety and Pharmacovigilance (PV) Software Products, Services and Solutions
5.8.4 United BioSource Corporation (US) Drug Safety and Pharmacovigilance (PV) Software Revenue (US$ Million) & (2016-2021)
5.8.5 United BioSource Corporation (US) Recent Developments
6 North America
6.1 North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Drug Safety and Pharmacovigilance (PV) Software Market Dynamics
11.1 Drug Safety and Pharmacovigilance (PV) Software Industry Trends
11.2 Drug Safety and Pharmacovigilance (PV) Software Market Drivers
11.3 Drug Safety and Pharmacovigilance (PV) Software Market Challenges
11.4 Drug Safety and Pharmacovigilance (PV) Software Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Figures, Tables and Charts Available in Global Drug Safety and Pharmacovigilance (PV) Software Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
List of TablesTable 1. Global Market Drug Safety and Pharmacovigilance (PV) Software Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027
Table 2. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2016-2021) & (US$ Million)
Table 3. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Share by Region (2016-2021)
Table 4. Global Drug Safety and Pharmacovigilance (PV) Software Forecasted Market Size by Region (2022-2027) & (US$ Million)
Table 5. Global Drug Safety and Pharmacovigilance (PV) Software Forecasted Market Size Share by Region (2022-2027)
Table 6. Global Drug Safety and Pharmacovigilance (PV) Software Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027
Table 7. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2016-2021) & (US$ Million)
Table 8. Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Type (2016-2021)
Table 9. Global Drug Safety and Pharmacovigilance (PV) Software Forecasted Market Size by Type (2022-2027) & (US$ Million)
Table 10. Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Type (2022-2027)
Table 11. Global Drug Safety and Pharmacovigilance (PV) Software Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027
Table 12. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2016-2021) & (US$ Million)
Table 13. Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Application (2016-2021)
Table 14. Global Drug Safety and Pharmacovigilance (PV) Software Forecasted Market Size by Application (2022-2027) & (US$ Million)
Table 15. Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Application (2022-2027)
Table 16. Global Drug Safety and Pharmacovigilance (PV) Software Revenue (US$ Million) by Players (2016-2021)
Table 17. Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Players (2016-2021)
Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug Safety and Pharmacovigilance (PV) Software as of 2020)
Table 19. Date of Key Manufacturers Enter into Drug Safety and Pharmacovigilance (PV) Software Market
Table 20. Global Drug Safety and Pharmacovigilance (PV) Software Top Players Headquarters and Area Served
Table 21. Drug Safety and Pharmacovigilance (PV) Software Product Solution and Service
Table 22. Global Drug Safety and Pharmacovigilance (PV) Software Players Market Concentration Ratio (CR5 and HHI)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. ArisGlobal (US) Basic Information List
Table 25. ArisGlobal (US) Description and Business Overview
Table 26. ArisGlobal (US) Drug Safety and Pharmacovigilance (PV) Software Products, Services and Solutions
Table 27. Revenue (US$ Million) in Drug Safety and Pharmacovigilance (PV) Software Business of ArisGlobal (US) (2016-2021)
Table 28. ArisGlobal (US) Recent Developments
Table 29. Ennov Solutions Inc. (US) Basic Information List
Table 30. Ennov Solutions Inc. (US) Description and Business Overview
Table 31. Ennov Solutions Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Products, Services and Solutions
Table 32. Revenue (US$ Million) in Drug Safety and Pharmacovigilance (PV) Software Business of Ennov Solutions Inc. (US) (2016-2021)
Table 33. Ennov Solutions Inc. (US) Recent Developments
Table 34. EXTEDO GmbH (US) Basic Information List
Table 35. EXTEDO GmbH (US) Description and Business Overview
Table 36. EXTEDO GmbH (US) Drug Safety and Pharmacovigilance (PV) Software Products, Services and Solutions
Table 37. Revenue (US$ Million) in Drug Safety and Pharmacovigilance (PV) Software Business of EXTEDO GmbH (US) (2016-2021)
Table 38. EXTEDO GmbH (US) Recent Developments
Table 39. Online Business Applications, Inc. (US) Basic Information List
Table 40. Online Business Applications, Inc. (US) Description and Business Overview
Table 41. Online Business Applications, Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Products, Services and Solutions
Table 42. Revenue (US$ Million) in Drug Safety and Pharmacovigilance (PV) Software Business of Online Business Applications, Inc. (US) (2016-2021)
Table 43. Online Business Applications, Inc. (US) Recent Developments
Table 44. Oracle Corporation (US) Basic Information List
Table 45. Oracle Corporation (US) Description and Business Overview
Table 46. Oracle Corporation (US) Drug Safety and Pharmacovigilance (PV) Software Products, Services and Solutions
Table 47. Revenue (US$ Million) in Drug Safety and Pharmacovigilance (PV) Software Business of Oracle Corporation (US) (2016-2021)
Table 48. Oracle Corporation (US) Recent Developments
Table 49. Sarjen Systems Pvt. Ltd (India) Basic Information List
Table 50. Sarjen Systems Pvt. Ltd (India) Description and Business Overview
Table 51. Sarjen Systems Pvt. Ltd (India) Drug Safety and Pharmacovigilance (PV) Software Products, Services and Solutions
Table 52. Revenue (US$ Million) in Drug Safety and Pharmacovigilance (PV) Software Business of Sarjen Systems Pvt. Ltd (India) (2016-2021)
Table 53. Sarjen Systems Pvt. Ltd (India) Recent Developments
Table 54. Sparta Systems, Inc. (US) Basic Information List
Table 55. Sparta Systems, Inc. (US) Description and Business Overview
Table 56. Sparta Systems, Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Products, Services and Solutions
Table 57. Revenue (US$ Million) in Drug Safety and Pharmacovigilance (PV) Software Business of Sparta Systems, Inc. (US) (2016-2021)
Table 58. Sparta Systems, Inc. (US) Recent Developments
Table 59. United BioSource Corporation (US) Basic Information List
Table 60. United BioSource Corporation (US) Description and Business Overview
Table 61. United BioSource Corporation (US) Drug Safety and Pharmacovigilance (PV) Software Products, Services and Solutions
Table 62. Revenue (US$ Million) in Drug Safety and Pharmacovigilance (PV) Software Business of United BioSource Corporation (US) (2016-2021)
Table 63. United BioSource Corporation (US) Recent Developments
Table 64. North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2016-2021) & (US$ Million)
Table 65. North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2022-2027) & (US$ Million)
Table 66. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2016-2021) & (US$ Million)
Table 67. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2022-2027) & (US$ Million)
Table 68. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2016-2021) & (US$ Million)
Table 69. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2022-2027) & (US$ Million)
Table 70. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Share by Region (2016-2021)
Table 71. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Share by Region (2022-2027)
Table 72. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2016-2021) & (US$ Million)
Table 73. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2022-2027) & (US$ Million)
Table 74. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Players (2016-2021) & (US$ Million)
Table 75. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2022-2027) & (US$ Million)
Table 76. Drug Safety and Pharmacovigilance (PV) Software Market Trends
Table 77. Drug Safety and Pharmacovigilance (PV) Software Market Drivers
Table 78. Drug Safety and Pharmacovigilance (PV) Software Market Challenges
Table 79. Drug Safety and Pharmacovigilance (PV) Software Market Restraints
Table 80. Research Programs/Design for This Report
Table 81. Key Data Information from Secondary Sources
Table 82. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Year-over-Year 2016-2027 & (US$ Million)
Figure 2. Global Drug Safety and Pharmacovigilance (PV) Software Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 3. Global Drug Safety and Pharmacovigilance (PV) Software Market Share by Regions: 2021 VS 2027
Figure 4. Global Drug Safety and Pharmacovigilance (PV) Software Forecasted Market Size Share by Region (2022-2027)
Figure 5. North America Drug Safety and Pharmacovigilance (PV) Software Market Size (US$ Million) Growth Rate (2016-2027)
Figure 6. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 7. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 8. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 9. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 10. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Share by Type in 2021 & 2027
Figure 11. On-Premises Market Size (US$ Million) YoY Growth (2016-2027)
Figure 12. Cloud-Based Market Size (US$ Million) YoY Growth (2016-2027)
Figure 13. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Share by Application in 2021 & 2027
Figure 14. Pharma and Biotech Companies Market Size (US$ Million) YoY Growth (2016-2027)
Figure 15. Contract Research Organizations (CROs) Market Size (US$ Million) YoY Growth (2016-2027)
Figure 16. Business Process Outsourcing (BPO) Firms Market Size (US$ Million) YoY Growth (2016-2027)
Figure 17. Other Market Size (US$ Million) YoY Growth (2016-2027)
Figure 18. Drug Safety and Pharmacovigilance (PV) Software Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 19. Global Top 5 and Top 10 Players Drug Safety and Pharmacovigilance (PV) Software Market Share in 2020
Figure 20. North America Drug Safety and Pharmacovigilance (PV) Software Market Share by Country (2016-2027)
Figure 21. United States Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027) & (US$ Million)
Figure 22. Canada Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027) & (US$ Million)
Figure 23. Germany Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027) & (US$ Million)
Figure 24. France Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027) & (US$ Million)
Figure 25. U.K. Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027) & (US$ Million)
Figure 26. Italy Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027) & (US$ Million)
Figure 27. Russia Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027) & (US$ Million)
Figure 28. Nordic Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027) & (US$ Million)
Figure 29. Rest of Europe Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027) & (US$ Million)
Figure 30. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Share by Region (2016-2027)
Figure 31. China Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027) & (US$ Million)
Figure 32. Japan Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027) & (US$ Million)
Figure 33. South Korea Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027) & (US$ Million)
Figure 34. Southeast Asia Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027) & (US$ Million)
Figure 35. India Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027) & (US$ Million)
Figure 36. Australia Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027) & (US$ Million)
Figure 37. Rest of Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027) & (US$ Million)
Figure 38. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Share by Country (2016-2027)
Figure 39. Mexico Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027) & (US$ Million)
Figure 40. Brazil Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027) & (US$ Million)
Figure 41. Rest of Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027) & (US$ Million)
Figure 42. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Share by Country (2016-2027)
Figure 43. Turkey Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027) & (US$ Million)
Figure 44. Saudi Arabia Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027) & (US$ Million)
Figure 45. UAE Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027) & (US$ Million)
Figure 46. Rest of Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027) & (US$ Million)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Keyplayers in Global Drug Safety and Pharmacovigilance (PV) Software Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
ArisGlobal (US)Ennov Solutions Inc. (US)
EXTEDO GmbH (US)
Online Business Applications, Inc. (US)
Oracle Corporation (US)
Sarjen Systems Pvt. Ltd (India)
Sparta Systems, Inc. (US)
United BioSource Corporation (US)
